col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


58 Ergebisse       Seite 1

 [1] 
Ovid: Infectious Diseases & Immunity
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Mai―07 Epidemiology, clinical overview, and potential risk of a new pandemic of measles virus Matteo Bassetti, Daniele Roberto Giacobbe, Chiara Sepulcri, Laura Labate
2 [GO] 2025―Apr―28 Viral persistence in long COVID: Research advances and treatment strategies Shiyang Liu, Yuming Guo, Fu-Sheng Wang
3 [GO] 2025―Apr―03 COVID-19 associated acute kidney injury Praveen Kumar Chandra Sekar, Ramakrishnan Veerabathiran
4 [GO] 2025―Mrz―04 Long COVID: current research and future directions Rongling Zhang, Xiaoying Gu, Hui Zhang, Yuming Guo, Bin Cao
5 [GO] 2024―Dez―17 Immune Response Dynamics to SARS-CoV-2 in the Albanian Population: A Study on T-Cell and Antibody Interactions During the Transition From Pandemic to Endemic Phase Genc Sulcebe, Erkena Shyti, Jonida Dashi-Pasholli, Margarita Kurti
6 [GO] 2024―Dez―13 Unraveling Coronavirus Cell Invasion: The Role of Glycan Receptors in Human Coronavirus-HKU1 Cell Entry Yan-Lin Yang, Zheng-Zhou Lu, Chu Xie, Lan-Yi Zhong, Cong Sun, Mu-Sheng Zeng
7 [GO] 2024―Nov―22 The Effectiveness of Convalescent Plasma Administered on the First Day of Admission for COVID-19 Patients: An Open-label Randomized Controlled Trial Saeed Mohammadi, Mandana Pouladzadeh, Hamidreza Kouhpayeh, Shamsi Okati, Mehdi Safdarian, Peyman Eshghi, et al. (+7)
8 [GO] 2024―Okt―19 Safety Profile of COVID-19 Vaccines in HIV Patients Undergoing ART and Their Impact on Immune Recovery and HIV Reservoirs Bing Song, Xinhua Wang, Lin Shen, Juan Cheng, Jing Tian, Chunjie Zhang, et al. (+11)
9 [GO] 2024―Sep―17 Expert consensus on the clinical application of oral small-molecule antiviral drugs against COVID-19
10 [GO] 2024―Jul―19 Original Antigenic Sin on Antibody Response in SARS-CoV-2 Infection Miao Wang, Huimin Guo, Bin Ju, Zheng Zhang
11 [GO] 2024―Apr―03 Challenges and Strategies for Influenza Response After COVID-19 Pandemic Jiaying Yang, Shuxia Lin, Yuelong Shu
12 [GO] 2024―Apr―03 Genetic Basis for Mucormycosis Progression in COVID-19 Patients: From Susceptibility to Severity Jethendra Kumar Muruganantham, Ramakrishnan Veerabathiran
13 [GO] 2024―Mrz―02 Clinical Epidemiology, Illness Profiles, and the Implication of COVID-19 Before and After the Nationwide Omicron Outbreak During the Winter of 2022: Erratum
14 [GO] 2024―Mrz―02 Alterations of SARS-CoV-2 Evolutionary Dynamics by Pharmaceutical Factors Matthew Halma
15 [GO] 2023―Okt―18 The Mechanisms of Luteolin in Treating COVID-19 Based on Bioinformatics Analysis and Molecular Docking Hechen Rong, Yu Zeng, Nan Zheng, Yiwei Wang, Zhonghong Guo, Kun Wang, Xiaoping Huang
16 [GO] 2023―Okt―18 Effect of Different Factors on the Quality of Life and Sequelae of COVID-19 Patients After Discharge Nan Guo, Ya-Ping Yao, Le Song, Guan-Zhen Wang, Jun-Li He, Ning Zheng, et al. (+5)
17 [GO] 2023―Okt―18 Immunogenicity of COVID-19 Vaccination in People Living with HIV: Progress and Challenges Jin-Wen Song, Lili Shen, Fu-Sheng Wang
18 [GO] 2023―Okt―18 Nomogram for Predicting Viral Shedding Time of SARS-CoV-2 Delta Variant in Patients with COVID-19: A Retrospective Study Jiejun Zhou, Lin Fan, Duo Li, Mingwei Chen, Tian Yang
19 [GO] 2023―Okt―18 Machine Learning-Based Scoring System for Early Prognosis Evaluation of Patients with Coronavirus Disease 2019 Hao-Min Zhang, Lei Shi, Hao-Ran Chen, Jun-Dong Zhang, Ge-Liang Liu, Zi-Ning Wang, et al. (+6)
20 [GO] 2023―Okt―18 Difference of Clinical Characteristics in Patients with Omicron and Delta Variants of SARS-CoV-2 in Beijing, China Di Tian, Yang Pan, Ziruo Ge, Xiangjing Kong, Yao Zhang, Qing Zhang, et al. (+3)
21 [GO] 2023―Sep―12 Survey on Changes in the Willingness to Receive the COVID-19 Vaccine Among Patients with Breast Cancer in the Postpandemic Era Lixiao Bai, Jianbin Li, Ailing Yang, Cuicui Ding, Jiayi Li, Yan Wang, et al. (+3)
22 [GO] 2023―Jun―26 Can Ursodeoxycholic Acid Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection or Reduce the Coronavirus Disease 2019 Severity? Current Knowledge and Unresolved Issues Shida Pan, Yang Zhang, Fanping Meng, Fu-Sheng Wang
23 [GO] 2023―Jun―26 Safety and Efficacy of SARS-CoV-2 Vaccination in Patients With Chronic Liver Disease Yu-Feng Mao, Lin Gao, Yuan-Yuan Li, Fu-Sheng Wang
24 [GO] 2023―Jun―02 Safety and Current Status of the COVID-19 Vaccine among Patients with Breast cancer: A Cross-Sectional Study from China Shaohua Zhang, Jianbin Li, Ruonan Xu, Qianjun Chen, Gang Sun, Ying Lin, et al. (+19)
25 [GO] 2023―Feb―07 A Case Report of a Pregnant Woman with COVID-19 and Tuberculosis Weiwei Song, Jingru Li, Nadila Abulizi, Tao Peng, Ke Fang, Na Xie, Zhanjun Shu
26 [GO] 2023―Feb―07 Advances in Research on COVID-19 Vaccination for People Living with HIV Junyan Jin, Xiuwen Wang, Raphael Carapito, Christiane Moog, Bin Su
27 [GO] 2023―Feb―07 Effect of Methylprednisolone on Mortality and Clinical Courses in Patients with Severe COVID-19: A Propensity Score Matching Analysis Xiaoyan Li, Xin Yuan, Zhe Xu, Lei Shi, Lei Huang, Xuechun Lu, Junliang Fu
28 [GO] 2023―Feb―07 Retrospective Analysis of the Duration of Hospitalization of Imported Patients Infected with SARS-CoV-2 in Guangzhou, 2021 Zhiwei Xie, Guofang Tang, Lu Li, Jingrong Shi, Qingxin Gan, Xiaowen Zheng, et al. (+13)
29 [GO] 2023―Feb―07 Characteristics and Potential Roles of Natural Killer Cells During SARS-CoV-2 Infection Wen-Jing Cao, Fu-Sheng Wang, Jin-Wen Song
30 [GO] 2023―Feb―07 Lipid-Based Poly(I:C) Adjuvants Strongly Enhance the Immunogenicity of SARS-CoV-2 Receptor-Binding Domain Vaccine Yixin Wu, Liuxian Meng, Huicong Zhang, Shun Hu, Fusheng Li, Yingjie Yu
31 [GO] 2022―Jul―20 Highly Prevalent SARS-CoV-2 Antigenemia in COVID-19 Patients Wenyan Zhang, Wei Liu, Jiawang Lin, Jing Jin, Kefu Zhao, Liwei Zhu, et al. (+13)
32 [GO] 2022―Jun―28 Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 9th Version)
33 [GO] 2022―Jun―27 Examination of Homologies between COVID-19 Vaccines and Common Allergens: The Potential for T Cell-mediated Responses for Allergic Rhinitis and Asthma Micah Hartwell, Benjamin H. Greiner, Savannah Nicks
34 [GO] 2022―Apr―26 Potential of Antibody-Dependent Cellular Cytotoxicity in Acute and Recovery Phases of SARS-CoV-2 Infection Tingting Cui, Mingzhu Huang, Xiaoling Su, Zhengfang Lin, Jiaying Zhong, Xiaoyun Yang, Zhongfang Wang
35 [GO] 2022―Feb―24 Establishment and Evaluation of a Prediction Model of BLR for Severity in Coronavirus Disease 2019 Zebao He, Fajuan Rui, Hongli Yang, Zhengming Ge, Rui Huang, Lingjun Ying, et al. (+3)
36 [GO] 2022―Jan―14 Risk Factors for Severity and Mortality in Adult Patients Confirmed with Covid-19 in Sierra Leone Bo Tu, Sulaiman Lakoh, Biao Xu, Marta Lado, Reginald Cole, Fang Chu, et al. (+5)
37 [GO] 2022―Jan―07 Prolonged Viral Shedding in Three Young Adult Cases of COVID-19 Wen-Yi Dong, Ming-Ju Zhou, Lei Huang, Chao Zhang, Fu-Sheng Wang, Zhou-Hua Xie
38 [GO] 2022―Jan―07 A COVID-19 Patient Discharged According to Strict Discharge Standards Enqiang Chen, Lichun Wang, Guangming Tang, Menglan Wang, Yachao Tao, Ping Feng, Hong Tang
39 [GO] 2021―Dez―30 Hemophagocytosis in a Severe COVID-19 Patient Kenneth I. Zheng, Xianghong Jin, Xuanru Lin, Hong Lu, Wenyue Liu, Minghua Zheng
40 [GO] 2021―Nov―05 Reinfection and Breakthrough Infection of SARS-CoV-2 Lin Gao, Xiuying Mu, Yan-Mei Jiao, Fu-Sheng Wang
41 [GO] 2021―Okt―20 Characterization of Specific Humoral Immunity in Asymptomatic SARS-CoV-2 Infection Yingying Deng, Jiaxin Zheng, Yong Lin, Ailong Huang
42 [GO] 2021―Sep―27 Expert Recommendation for Novel Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in HIV-Infected Adults
43 [GO] 2021―Sep―27 Expert Recommendation on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Patients with Chronic Liver Diseases, Tuberculosis or Rheumatoid Diseases
44 [GO] 2021―Sep―06 Acute-on-Chronic Liver Failure Precipitated by Severe Acute Respiratory Syndrome Coronavirus 2 Infection in a Patient with Hepatitis B Virus-Related Cirrhosis Wanling Chen, Qiran Zhang, Shijun Li, Ruiting Liang, Haiqun Liang, Yiqi Yu, et al. (+3)
45 [GO] 2021―Sep―01 SARS-CoV-2 Variants Baoying Huang, Wenjie Tan
46 [GO] 2021―Aug―13 Opinion on the Policy of Lifting Restrictions to Entry Under the Circumstance of the COVID-19 Pandemic Ailong Huang, Jieli Hu, Hong Zhang
47 [GO] 2021―Aug―13 WHO-Convened Global Study of Origins of SARS-CoV-2
48 [GO] 2021―Aug―05 Systematic Discovery and Pathway Analyses of Metabolic Disturbance in COVID-19 Bo-Wen Li, Xing Fan, Wen-Jing Cao, He Tian, Si-Yu Wang, Ji-Yuan Zhang, et al. (+12)
49 [GO] 2021―Aug―05 The Pathogenesis of COVID-19 Indicates Therapeutic Strategies Tai-Sheng Li, Ling Lin
50 [GO] 2021―Aug―05 Changes of Damage Associated Molecular Patterns in COVID-19 Patients Xing Fan, Jin-Wen Song, Si-Yu Wang, Wen-Jing Cao, Xiu-Wen Wang, Ming-Ju Zhou, et al. (+8)
51 [GO] 2021―Aug―05 Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 8th Edition)
52 [GO] 2021―Aug―05 Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 8th Edition): Interpretation of Updated Key Points Gui-Qiang Wang, Lei Zhao, Xia Wang, Yan-Mei Jiao, Fu-Sheng Wang
53 [GO] 2021―Aug―05 The COVID-19 Vaccine in Clinical Trials: Where Are We Now? Hu-Dachuan Jiang, Jing-Xin Li, Peng Zhang, Xiang Huo, Feng-Cai Zhu
54 [GO] 2021―Aug―05 Keep Eyes on COVID-19: Ophthalmic Symptoms and Potential Transmission of SARS-CoV-2 through the Oculus Hong Li Ran, Xiang Tian Zhou, William J. Liu, George F. Gao
55 [GO] 2021―Aug―05 The Progress and Challenges of Convalescent Plasma Therapy for Coronavirus Disease 2019 Ming Shi, Chao Zhang, Fu-Sheng Wang
56 [GO] 2021―Aug―05 Diagnosis and Treatment Guidelines for Mesenchymal Stem Cell Therapy for Coronavirus Disease 2019 (Beijing, 2021) Ruonan Xu, Lei Shi, Wei-Fen Xie, Zhe Xu, Fan-Ping Meng, Jun-Liang Fu, et al. (+25)
57 [GO] 2021―Aug―05 CAPRL Scoring System for Prediction of 30-day Mortality in 949 Patients with Coronavirus Disease 2019 in Wuhan, China: A Retrospective, Observational Study Hui-Long Chen, Wei-Ming Yan, Guang Chen, Xiao-Yun Zhang, Zhi-Lin Zeng, Xiao-Jing Wang, et al. (+25)
58 [GO] 2021―Aug―05 Origins of SARS-CoV-2: Focusing on Science Zheng-Li Shi
 [1] 

58 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec